Cargando…
Modern basal insulin analogs: An incomplete story
The currently available basal insulin does not completely mimic the endogenous insulin secretion. This has continued to promote the search for ideal basal insulin. The newer basal insulin have primarily focused on increasing the duration of action, reducing variability, and reducing the incidence of...
Autores principales: | Singh, Awadhesh Kumar, Gangopadhyay, Kalyan Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192982/ https://www.ncbi.nlm.nih.gov/pubmed/25364672 http://dx.doi.org/10.4103/2230-8210.140239 |
Ejemplares similares
-
Clinical experience with insulin detemir, biphasic insulin aspart and insulin aspart in people with type 2 diabetes: Results from the Kolkata cohort of the A(1)chieve study
por: Majumder, Anirban, et al.
Publicado: (2013) -
Consensus Statement on Dose Modifications of Antidiabetic Agents in Patients with Hepatic Impairment
por: Gangopadhyay, Kalyan Kumar, et al.
Publicado: (2017) -
Is insulin degludec a more effective treatment for patients using high doses of insulin glargine but not attaining euglycemia? Some case reports from India
por: Sinha, Binayak, et al.
Publicado: (2014) -
Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs
por: Poon, Kitty, et al.
Publicado: (2010) -
Incompletely excised basal cell carcinomas: Our guidelines
por: Longhi, P, et al.
Publicado: (2008)